Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:04 PM
Akero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 4K | n/a | n/a | n/a | 284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 2K | 1K | 1K | 1K | 2K | 5K | 69K | 68K | 65K | 66K | 65K | 64K | 63K | 60K | 60K | 61K |
Gross Profit | n/a | n/a | 2K | -1K | -1K | -1K | -2K | -5K | -69K | -68K | -65K | -66K | -65K | -64K | -63K | -60K | -60K | -61K |
Operating Income | -80.87M | -80.88M | -78.03M | -81.7M | -65.74M | -59.95M | -61.87M | -46.62M | -35.63M | -28.75M | -25.42M | -36.09M | -27.59M | -26.05M | -32.44M | -24.35M | -28.97M | -15.13M |
Interest Income | 11.54M | 11.31M | 9.2M | 10.24M | 10.98M | 7.6M | 7.58M | 7.84M | 5.4M | 3.38M | n/a | n/a | 244K | 22K | n/a | n/a | n/a | 38K |
Pretax Income | -70.5M | -70.72M | -70.02M | -72.7M | -55.99M | -53.34M | -55.19M | -39.66M | -31.08M | -25.83M | -23.06M | -35.54M | -27.4M | -26.03M | -32.42M | -24.33M | -28.93M | -15.09M |
Net Income | -70.5M | -70.72M | -70.02M | -72.7M | -55.99M | -53.34M | -55.19M | -39.66M | -31.08M | -23.37M | -20.48M | -34.99M | -27.4M | -26.01M | -32.42M | -24.33M | -28.93M | -15.09M |
Selling & General & Admin | 11.62M | 11.31M | 8.73M | 9.47M | 10.42M | 9.3M | 8.48M | 7.98M | 7.64M | 6.97M | 7.1M | 11M | 6.23M | 5.54M | 4.73M | 4.88M | 4.99M | 4.53M |
Research & Development | 69.25M | 69.57M | 69.29M | 72.23M | 55.32M | 50.65M | 53.39M | 38.63M | 27.98M | 21.79M | 18.32M | 25.09M | 21.36M | 20.51M | 27.71M | 19.47M | 23.98M | 10.6M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 244K | n/a | 15K | 23K | 33K | 38K |
Operating Expenses | 80.87M | 80.88M | 78.03M | 81.7M | 65.74M | 59.95M | 61.87M | 46.62M | 35.63M | 28.75M | 25.42M | 36.09M | 27.59M | 26.05M | 32.44M | 24.35M | 28.97M | 15.13M |
Interest Expense | 1.17M | -1.15M | 1.2M | 1.25M | 1.23M | 991K | 897K | 888K | 857K | 457K | 362K | 324K | 53K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1K | -1K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 80.87M | 80.88M | 78.03M | 81.7M | 65.74M | 59.95M | 61.87M | 46.62M | 35.63M | 28.75M | 25.42M | 36.09M | 27.59M | 26.05M | 32.44M | 24.35M | 28.97M | 15.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -42.28K | n/a | n/a | n/a | -2.46M | -2.57M | -549K | n/a | -22K | -11K | -51K | -50K | -50K |
Shares Outstanding (Basic) | 81.72M | 78.66M | 70.57M | 69.44M | 69.16M | 59.31M | 55.72M | 55.61M | 51.87M | 46.94M | 46.76M | 38.66M | 35.38M | 35.01M | 34.89M | 34.86M | 34.81M | 34.74M |
Shares Outstanding (Diluted) | 81.72M | 78.66M | 70.57M | 69.44M | 69.16M | 59.31M | 55.72M | 55.61M | 51.87M | 46.94M | 46.76M | 38.66M | 35.38M | 35.01M | 34.89M | 34.86M | 34.81M | 34.74M |
EPS (Basic) | -0.86 | -0.9 | -0.99 | -1.05 | -0.81 | -0.9 | -0.99 | -0.71 | -0.6 | -0.5 | -0.44 | -0.91 | -0.77 | -0.74 | -0.93 | -0.7 | -0.83 | -0.43 |
EPS (Diluted) | -0.86 | -0.9 | -0.99 | -1.05 | -0.81 | -0.9 | -0.99 | -0.71 | -0.6 | -0.5 | -0.44 | -0.91 | -0.77 | -0.74 | -0.93 | -0.7 | -0.83 | -0.43 |
EBITDA | -69.33M | -69.57M | -68.81M | -71.46M | -54.76M | -52.35M | -54.29M | -38.77M | -30.16M | -25.31M | -22.63M | -35.15M | -27.29M | -25.96M | -32.43M | -24.27M | -28.87M | -15.12M |
EBIT | -69.33M | -69.57M | -68.82M | -71.46M | -54.76M | -52.35M | -54.29M | -38.77M | -30.23M | -25.37M | -22.7M | -35.22M | -27.35M | -26.03M | -32.44M | -24.33M | -28.93M | -15.13M |
Depreciation & Amortization | n/a | 4.5K | 15K | 1K | 1K | 1K | 2K | 5K | 69K | 68K | 65K | 66K | 65K | 64K | 63K | 60K | 60K | 61K |